Ullah, M.; Mirshahi, S.; Valinattaj Omran, A.; Aldybiat, I.; Crepaux, S.; Soria, J.; Contant, G.; Pocard, M.; Mirshahi, M.
Blood Clot Dynamics and Fibrinolysis Impairment in Cancer: The Role of Plasma Histones and DNA. Cancers 2024, 16, 928.
https://doi.org/10.3390/cancers16050928
AMA Style
Ullah M, Mirshahi S, Valinattaj Omran A, Aldybiat I, Crepaux S, Soria J, Contant G, Pocard M, Mirshahi M.
Blood Clot Dynamics and Fibrinolysis Impairment in Cancer: The Role of Plasma Histones and DNA. Cancers. 2024; 16(5):928.
https://doi.org/10.3390/cancers16050928
Chicago/Turabian Style
Ullah, Matti, Shahsoltan Mirshahi, Azadeh Valinattaj Omran, Iman Aldybiat, Sullyvan Crepaux, Jeannette Soria, Geneviève Contant, Marc Pocard, and Massoud Mirshahi.
2024. "Blood Clot Dynamics and Fibrinolysis Impairment in Cancer: The Role of Plasma Histones and DNA" Cancers 16, no. 5: 928.
https://doi.org/10.3390/cancers16050928
APA Style
Ullah, M., Mirshahi, S., Valinattaj Omran, A., Aldybiat, I., Crepaux, S., Soria, J., Contant, G., Pocard, M., & Mirshahi, M.
(2024). Blood Clot Dynamics and Fibrinolysis Impairment in Cancer: The Role of Plasma Histones and DNA. Cancers, 16(5), 928.
https://doi.org/10.3390/cancers16050928
